Project

TB Innovations and Health Systems Strengthening

TB Innovations and Health Systems Strengthening (TB Innovations) is a five-year project designed to bring a dynamic and strategic approach to accelerate the fight against tuberculosis (TB) in the Philippines and to institute health processes and systems that help the country achieve its targets for TB elimination by 2035.

The project is funded by the U.S. Agency for International Development (USAID) to identify, develop, pilot and scale up game-changing, innovative technologies and approaches to assist the Philippines government in reaching national targets. FHI 360 will work closely with the National TB Program, USAID, USAID partners, the World Health Organization, the Global Fund and in-country stakeholders to achieve the broader vision and support the attainment of the Philippines Health Agenda.

TB Innovations has these objectives:

  • Identify approaches to maximize case detection and health-seeking behavior
  • Integrate and institutionalize practices to improve treatment adherence and quality of care
  • Create a supportive environment encompassing the continuum of TB prevention to care

Project activities focus on patient outcomes and include:

  • Rapidly expand state-of-the-art case detection, appropriate treatment-seeking behavior and treatment adherence interventions for vulnerable and high-risk populations
  • Integrate and institutionalize high-impact practices to improve the quality of care for patients with TB and multidrug-resistant TB in the public and non-public sectors
  • Implement TB screening at all health facilities, congregate settings and improve referral networks for testing and treatment 
  • Optimize TB diagnostic networks to use existing tools and incorporate innovative approaches
  • Integrate gender considerations into every aspect of programming
  • Use baseline sustainability analysis and ongoing monitoring to strengthen policy, financial and programmatic sustainability
Countries:
  • Philippines
Funder: USAID
Duration: 2018 - 2023